14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of NVIV
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

FAQ

What is the symbol for InVivo Therapeutics Holdings Corp. Stock and on which exchange is it traded?
The symbol for InVivo Therapeutics Holdings Corp. is NVIV and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell InVivo Therapeutics Holdings Corp. Stock?
InVivo Therapeutics Holdings Corp. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy InVivo Therapeutics Holdings Corp. Stock?
InVivo Therapeutics Holdings Corp. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy InVivo Therapeutics Holdings Corp. Stock.

What's the current price of InVivo Therapeutics Holdings Corp. Stock?
As of the end of day on the Apr 25, 2024, the price of an InVivo Therapeutics Holdings Corp. (NVIV) share was $0.321.

What is the 52-week high and low for InVivo Therapeutics Holdings Corp. Stock?
The 52-week high for InVivo Therapeutics Holdings Corp. Stock is $1.64 and the 52-week low is $0.222.

What is the market capitalization of InVivo Therapeutics Holdings Corp. Stock?
As of the Apr 25, 2024, the market capitalization of InVivo Therapeutics Holdings Corp. is 995.918K.
Click to get the best stock tips daily for free!

About InVivo Therapeutics Holdings Corp.

InVivo Therapeutics Holdings . InVivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). It is developing a Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord to treat acute SCI. The company was ... NVIV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT